Mainz BioMed N.V. | WebDisclosure

Basculer en Français

9480	Companies
185531	Keywords
117919	Articles
99374	Press releases

Home
Companies
Mainz BioMed N.V.

PRESS RELEASE

published on 04/28/2025 at 14:04, 7 months 7 days ago

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
Mainz Biomed provides Q1 2025 corporate update on FDA premarket approval path, including study enrollment, partnership with Liquid Biosciences and labor team w ag, and product launches. CEO Guido Baechler comments on progress

FDA ColoAlert Mainz Biomed Q1 2025 Premarket Approval
BRIEF

published on 04/01/2025 at 14:06, 8 months 4 days ago

Mainz Biomed Releases 2024 Financial Results

Financial Results Strategic Partnerships Nasdaq Compliance Mainz Biomed Colorectal Cancer Screening
BRIEF

published on 04/01/2025 at 14:06, 8 months 4 days ago

Mainz Biomed publie ses résultats financiers pour 2024

Résultats Financiers Partenariats Stratégiques Mayence Biomed Conformité NASDAQ Dépistage Du Cancer Colorectal
PRESS RELEASE

published on 04/01/2025 at 14:01, 8 months 4 days ago

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
Mainz Biomed N.V. reports 2024 financial results, highlights lab network revenue growth by 33% and strategic partnerships, updates on corporate developments for early 2025

Strategic Partnerships Corporate Update Mainz Biomed N.V. 2024 Financial Results Lab Network Revenue
BRIEF

published on 03/27/2025 at 14:06, 8 months 9 days ago

Mainz Biomed lance l'étude clinique eAArly DETECT 2

Cancer Colorectal Mayence Biomed Étude Clinique Biomarqueurs D'ARNm Détection Des Précancéreux
BRIEF

published on 03/27/2025 at 14:06, 8 months 9 days ago

Mainz Biomed Launches eAArly DETECT 2 Clinical Study

Clinical Study Mainz Biomed Colorectal Cancer MRNA Biomarkers Precancerous Detection
PRESS RELEASE

published on 03/27/2025 at 14:01, 8 months 9 days ago

Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
Mainz Biomed enrolls the first patient in the eAArly DETECT 2 Clinical Study to validate industry-leading results for detecting advanced precancerous lesions. Top-line results expected in Q4 2025

Clinical Study Early Detection Mainz Biomed EAArly DETECT 2 Advanced Precancerous Lesions
BRIEF

published on 03/13/2025 at 14:06, 8 months 23 days ago

Mainz Biomed et Liquid Biosciences dévoilent de nouveaux biomarqueurs d'ARNm pour la détection du cancer du pancréas

Mayence Biomed Biomarqueurs D'ARNm Cancer Du Pancréas Biosciences Liquides Détection Par Test Sanguin
BRIEF

published on 03/13/2025 at 14:06, 8 months 23 days ago

Mainz Biomed and Liquid Biosciences Unveil Novel mRNA Biomarkers for Pancreatic Cancer Detection

Mainz Biomed MRNA Biomarkers Pancreatic Cancer Liquid Biosciences Blood Test Detection
PRESS RELEASE

published on 03/13/2025 at 14:01, 8 months 23 days ago

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Mainz Biomed and Liquid Biosciences make groundbreaking discovery of mRNA biomarkers for blood-based detection of pancreatic cancer, achieving transformative sensitivity of 95% and specificity of 98%

Mainz Biomed MRNA Biomarkers Pancreatic Cancer Liquid Biosciences Blood-based Detection

Accesswire

Published on 12/05/2025 at 19:20, 4 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 39 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 4 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 24 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 9 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 25 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 57 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 8 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 32 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 37 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 5 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 5 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 13 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 13 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 25 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE